ArticleFrontiers in immunology2022

A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies.

Eizo Takashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.